Literature DB >> 19176470

Psychosocial treatments to promote functional recovery in schizophrenia.

Robert S Kern1, Shirley M Glynn, William P Horan, Stephen R Marder.   

Abstract

A number of psychosocial treatments are available for persons with schizophrenia that include social skills training, cognitive behavioral therapy, cognitive remediation, and social cognition training. These treatments are reviewed and discussed in terms of how they address key components of functional recovery such as symptom stability, independent living, work functioning, and social functioning. We also review findings on the interaction between pharmacological and psychosocial treatments and discuss future directions in pharmacological treatment of schizophrenia. Overall, these treatments provide a range of promising approaches to helping patients achieve better outcomes far beyond symptom stabilization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176470      PMCID: PMC2659313          DOI: 10.1093/schbul/sbn177

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  110 in total

Review 1.  The neurobiology of social cognition.

Authors:  R Adolphs
Journal:  Curr Opin Neurobiol       Date:  2001-04       Impact factor: 6.627

2.  Remediation of memory disorders in schizophrenia.

Authors:  A Medalia; N Revheim; M Casey
Journal:  Psychol Med       Date:  2000-11       Impact factor: 7.723

3.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

4.  A meta-analysis of controlled research on social skills training for schizophrenia.

Authors:  Matthew M Kurtz; Kim T Mueser
Journal:  J Consult Clin Psychol       Date:  2008-06

Review 5.  The psychosocial treatment of schizophrenia: an update.

Authors:  J Bustillo; J Lauriello; W Horan; S Keith
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

6.  Effects of attention training on information processing in schizophrenia.

Authors:  R H Benedict; A E Harris; T Markow; J A McCormick; K H Nuechterlein; R F Asarnow
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

7.  The mnemonic mechanisms of errorless learning.

Authors:  Nicole D Anderson; Fergus I M Craik
Journal:  Neuropsychologia       Date:  2006-08-09       Impact factor: 3.139

8.  Can verbalization remedy the theory of mind deficit in schizophrenia?

Authors:  Y Sarfati; C Passerieux; M Hardy-Baylé
Journal:  Psychopathology       Date:  2000 Sep-Oct       Impact factor: 1.944

Review 9.  Cognitive-behavioral therapy for schizophrenia: a review.

Authors:  Douglas Turkington; Robert Dudley; Debbie M Warman; Aaron T Beck
Journal:  J Psychiatr Pract       Date:  2004-01       Impact factor: 1.325

10.  Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia.

Authors:  R P Liberman; C J Wallace; G Blackwell; A Kopelowicz; J V Vaccaro; J Mintz
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

View more
  65 in total

Review 1.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

2.  Perspectives on schizophrenia over the lifespan: a qualitative study.

Authors:  Sally Shepherd; Colin A Depp; Gloria Harris; Maureen Halpain; Lawrence A Palinkas; Dilip V Jeste
Journal:  Schizophr Bull       Date:  2010-07-05       Impact factor: 9.306

Review 3.  Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.

Authors:  Kerri L Tang; Kevin M Antshel; Wanda P Fremont; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2015-10       Impact factor: 2.225

4.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

5.  Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Schizophr Res       Date:  2015-06-01       Impact factor: 4.939

6.  Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.

Authors:  Shelly L Babin; Ashley J Hood; Adel A Wassef; Nina G Williams; Saumil S Patel; Anne B Sereno
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-06-13       Impact factor: 5.067

7.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

8.  Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia.

Authors:  William P Horan; Yuri Rassovsky; Robert S Kern; Junghee Lee; Jonathan K Wynn; Michael F Green
Journal:  J Psychiatr Res       Date:  2009-12-14       Impact factor: 4.791

9.  Health and wellness photovoice project: engaging consumers with serious mental illness in health care interventions.

Authors:  Leopoldo J Cabassa; Angela Parcesepe; Andel Nicasio; Ellen Baxter; Sam Tsemberis; Roberto Lewis-Fernández
Journal:  Qual Health Res       Date:  2012-12-20

10.  Effects of perceived social status and discrimination on hope and empowerment among individuals with serious mental illnesses.

Authors:  Stephanie Langlois; Luca Pauselli; Simone Anderson; Oluwatoyin Ashekun; Samantha Ellis; JaShala Graves; Adria Zern; Ebony Gaffney; Ruth S Shim; Michael T Compton
Journal:  Psychiatry Res       Date:  2020-02-08       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.